Clinical Trials Logo

Neuromuscular Blockade clinical trials

View clinical trials related to Neuromuscular Blockade.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT04816539 Not yet recruiting - Clinical trials for Neuromuscular Blockade

Comparison of the TOFscan and the TetraGraph During Recovery of Neuromuscular Function

DECURAR-EMG
Start date: April 15, 2021
Phase:
Study type: Observational

Assess the values of train-of-four ratios with the TetraGraph and thoses obtained with the TOFscan during recovery of neuromusculat function in surgical patients who have been administred rocuronium. Primary outcome : value of TOFratio with the TetraGraph when TOFratio of TOFscan is greater than or equal to 90% Pilot study : no hypothesis

NCT ID: NCT04808947 Not yet recruiting - Clinical trials for Neuromuscular Blockade

LIA vs. LIA + ACB-iPACK Block for Total Knee Arthroplasty

Start date: April 2024
Phase: N/A
Study type: Interventional

LIA is the mainstay of postoperative analgesia in patients having knee arthroplasty. The combination of ACB-iPACK blocks has also been proposed as an effective analgesic modality for total knee arthroplasty. However, whether combining these two modalities yields any important incremental analgesic benefit remains unclear. The investigators hypothesized that the addition of ACB and iPACK blocks to LIA will yield clinically important analgesic benefits compared to LIA alone in patients having total knee arthroplasty.

NCT ID: NCT04259112 Not yet recruiting - Diabetes Mellitus Clinical Trials

Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Deep neuromuscular block is defined as post tetanic count (PTC) 1-2, and low neuromuscular block is defined as train-of-four (TOF) twitch 1-2. The outcomes will be indicators for acute kidney injury and surgical condition.

NCT ID: NCT04096144 Not yet recruiting - Clinical trials for Neuromuscular Blockade

Comparison of Sugammadex and Neostigmine During PACU Stay

Start date: October 15, 2019
Phase: Phase 3
Study type: Interventional

Sugammadex was approved for post-operative use in the operating room (OR) and post-anesthesia recovery unit (PACU) of our quaternary facility, Tampa General Hospital. The approval came with administrative limitations: 2mg/kg dose only and for the first year its utilization was limited as replacement for up to half of Neostigmine/Glycopyrrolate use. An MUE evaluation was completed for a retrospective chart review from March 2017 to December 2017 (10 months) to assess all cases in which patients received Sugammadex or Neostigmine. During the year of data collection, we also noted a widespread tendency to reduce the usage of narcotics. A t-test comparison of the length of stay (LOS) in the PACU revealed a highly significant difference between the LOS in PACU for both drugs. On average, patients receiving Sugammadex were discharged from the PACU 43 minutes earlier than patients who received Neostigmine/Glycopyrrolate. The patient mix in both groups was similar, but these data were obtained retrospectively by a pharmacy chart review.

NCT ID: NCT03978780 Not yet recruiting - Breast Cancer Clinical Trials

Erector Spinae Block vs. Placebo Block Study

Start date: September 2024
Phase: N/A
Study type: Interventional

Regional anaesthesia combined with general anaesthesia has become common in the perioperative management of breast cancer surgery patients. Regional techniques have been recognised to provide excellent post-operative analgesia. It enhances multi-modal analgesia regimes while being opioid sparing, reducing incidence of post-operative nausea and vomiting and allowing earlier mobilisation/discharge and improving treatment success. Therefore identifying the correct regional anaesthetic technique for this group of patients is important in providing optimum peri-operative care.

NCT ID: NCT03660891 Not yet recruiting - Clinical trials for Neuromuscular Blockade

OS NMB Depth Measured by Central and Peripheral Monitor.

Start date: August 1, 2020
Phase:
Study type: Observational

Comparing during anesthesia in the same patient 2 neuromuscular monitors on the same arm.

NCT ID: NCT02601508 Not yet recruiting - Clinical trials for Neuromuscular Blockade

Compare of Surgical Condition and Complications With Moderate and Deep NM Block

MISPCNUHH
Start date: November 2015
Phase: N/A
Study type: Interventional

This study is designed to evaluate the surgeon's satisfaction with either deep or moderate neuromuscular blockade during laparoscopic gastrectomy surgery and observe the recovery profiles in the recovery room and the ward.The explorative objective of this study is to evaluate the safety profiles of deep and moderate neuromuscular blockades via observation of postoperative complications.

NCT ID: NCT02387021 Not yet recruiting - Clinical trials for Neuromuscular Blockade

Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether the association of sciatic nerve block to continuous adductor canal block is effective in the treatment of total knee arthroplasty post operative pain .